291778-77-3
291778-77-3 結(jié)構(gòu)式
基本信息
1-Imidazolidineacetic acid, 3-[2-[[(1S)-2-methyl-1-[[(2S)-2-[[[(1S)-3,3,3-trifluoro-1-(1-methylethyl)-2-oxopropyl]amino]carbonyl]-1-pyrrolidinyl]carbonyl]propyl]amino]-2-oxoethyl]-2-oxo-
| 報(bào)價(jià)日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價(jià)格 |
| 2026/06/05 | HY-19406 | AE-3763 | 291778-77-3 | 1 mg | 1450元 |
| 2026/06/05 | HY-19406 | 291778-77-3 AE-3763 | 291778-77-3 | 5mg | 3650元 |
| 2026/06/05 | HY-19406 | 291778-77-3 AE-3763 | 291778-77-3 | 10 mM * 1 mLin DMSO | 4413元 |
常見問題列表
IC50: 29 nM (Human neutrophil elastase)
AE-3763 exhibits potent in vitro inhibitory activity against human neutrophil elastase as well as extremely high solubility and stability in water.
Edema and leukocytes infiltration into the lung are significantly inhibited by infusion of AE-3763. AE3763 significantly improves survival rate by 24 h in a mouse model of fatal shock associated with multiple organ dysfunction. AE-3763 dose-dependently prevents hemorrhage when given intravenously by infusion (ED 50 : 0.42 mg/kg/h) or by bolus injection (1.2 mg/kg). With regard to the toxicity of AE-3763 in mice, the results of a preliminary study have shown no overt toxic effect even at the high dose of 300 mg/kg, iv.